Eric Johnson

JSR Corp. engages in the manufacture and sale of synthetic rubber and fine chemical materials. It operates through the following segments: Elastomers, Synthetic Resin, Digital Solution, Life Science and Others. The Elastomers segment produces and merchandises general purpose synthetic rubber for automobile tires, special high performance rubber for automotive components, thermoplastic elastomers for plastic enhancements, and emulsion for paper coating. The Synthetic Resin segment manufactures and sells Acrylonitrile, Butadiene, and Styrene (ABS) plastic for office automation equipment and amusement application. The Digital Solution segment produces and markets semiconductor, display, and optical materials. The Life Science segment handles diagnostics, research reagents and related materials, and bio process manufacturing and development consignment. The Others segment covers lithium ion capacitor business. The company was founded on December 8, 1948 and is headquartered in Tokyo, Japan.

Part of JSR Corp., JSR Micro, Inc. is a company that manufactures organic chemicals. The company is based in Sunnyvale, CA. Founded in 1990.

KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.

Part of JSR Corp., JSR North America Holdings, Inc. is a company that serves clients in the semiconductor, drug discovery, biopharmaceutical, clinical research, and clean energy solutions markets. The company is based in Sunnyvale, CA.

Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland.